Bioimmunate Technologies Ltd.
Sigalit Carmel is the current CEO of Bioimmunate Technologies Ltd. Sigalit previously worked as a PHD Researcher at Hebrew University, focusing on the Autoimmunity field. Prior to that, Sigalit served as a Medical Doctor at CICU in Sheba Tel HaShomer City of Health. Sigalit holds a Doctor of Medicine (M.D.) degree from The Hebrew University of Jerusalem.
This person is not in any teams
This person is not in any offices
Bioimmunate Technologies Ltd.
BIOIMMUNATE TECHNOLOGIES Ltd. develops innovative personalized medical platform to treat autoimmune diseases. We create breakthrough precise medicine technology of blood filtration to autoimmune diseases based on removal of harm cells from the human body. BIOIMMUNATE current R&D is focused on multiple sclerosis (MS) patients.